WO2001051635A3 - Novel stra6 polypeptides - Google Patents
Novel stra6 polypeptides Download PDFInfo
- Publication number
- WO2001051635A3 WO2001051635A3 PCT/US2001/000847 US0100847W WO0151635A3 WO 2001051635 A3 WO2001051635 A3 WO 2001051635A3 US 0100847 W US0100847 W US 0100847W WO 0151635 A3 WO0151635 A3 WO 0151635A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- present
- nucleic acid
- novel
- sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60137829T DE60137829D1 (en) | 2000-01-13 | 2001-01-11 | HUMAN STRA6 POLYPEPTIDE |
CN018064965A CN1425066B (en) | 2000-01-13 | 2001-01-11 | Novel stra6 polypeptides |
EP01904821A EP1246917B1 (en) | 2000-01-13 | 2001-01-11 | Human stra6 polypeptides |
NZ520095A NZ520095A (en) | 2000-01-13 | 2001-01-11 | Novel Stra6 polypeptides, nucleic acids, antibodies, compositions and methods of treatments for inhibiting tumor cell growth |
CA2397207A CA2397207C (en) | 2000-01-13 | 2001-01-11 | Novel stra6 polypeptides |
DK01904821T DK1246917T3 (en) | 2000-01-13 | 2001-01-11 | Human Stra6 polypeptides |
AU32768/01A AU785055B2 (en) | 2000-01-13 | 2001-01-11 | Novel stra6 polypeptides |
IL15067601A IL150676A0 (en) | 2000-01-13 | 2001-01-11 | NOVEL STRa6 POLYPEPTIDES |
JP2001551209A JP2003519491A (en) | 2000-01-13 | 2001-01-11 | Novel STRA6 polypeptide |
US10/119,480 US20040087769A1 (en) | 1998-09-10 | 2002-04-09 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
IL150676A IL150676A (en) | 2000-01-13 | 2002-07-10 | Stra6 antibodies and uses thereof |
KR1020027009049A KR100929057B1 (en) | 2000-01-13 | 2002-07-12 | New Stratea6 Polypeptide |
AU2006241374A AU2006241374B2 (en) | 2000-01-13 | 2006-11-24 | Novel Stra6 polypeptides |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17584900P | 2000-01-13 | 2000-01-13 | |
US60/175,849 | 2000-01-13 | ||
US19708900P | 2000-04-14 | 2000-04-14 | |
US60/197,089 | 2000-04-14 | ||
US22891400P | 2000-08-29 | 2000-08-29 | |
US60/228,914 | 2000-08-29 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/119,480 Continuation US20040087769A1 (en) | 1998-09-10 | 2002-04-09 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001051635A2 WO2001051635A2 (en) | 2001-07-19 |
WO2001051635A3 true WO2001051635A3 (en) | 2002-05-02 |
Family
ID=27390600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/000847 WO2001051635A2 (en) | 1998-09-10 | 2001-01-11 | Novel stra6 polypeptides |
Country Status (15)
Country | Link |
---|---|
US (7) | US7173115B2 (en) |
EP (1) | EP1246917B1 (en) |
JP (2) | JP2003519491A (en) |
KR (2) | KR20080006002A (en) |
CN (2) | CN101643733A (en) |
AT (1) | ATE424457T1 (en) |
AU (2) | AU785055B2 (en) |
CA (1) | CA2397207C (en) |
DE (1) | DE60137829D1 (en) |
DK (1) | DK1246917T3 (en) |
ES (1) | ES2323220T3 (en) |
IL (2) | IL150676A0 (en) |
NZ (1) | NZ520095A (en) |
PT (1) | PT1246917E (en) |
WO (1) | WO2001051635A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE424457T1 (en) * | 2000-01-13 | 2009-03-15 | Genentech Inc | HUMAN STRA6 POLYPEPTIDES |
EP1334126A1 (en) * | 2000-03-23 | 2003-08-13 | Curagen Corporation | Human stra6-like protein and nucleic acids encoding the same |
CN1339489A (en) * | 2000-08-23 | 2002-03-13 | 上海博德基因开发有限公司 | New polypeptide-human retinoic acid modulator protein 53.57 and polynucleotide for encoding such polypeptide |
DE60140966D1 (en) * | 2000-08-29 | 2010-02-11 | Genentech Inc | Method for improving cancer therapy |
US7682607B2 (en) * | 2001-05-01 | 2010-03-23 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
EP2799555B1 (en) * | 2002-03-13 | 2017-02-22 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
US7666627B2 (en) * | 2002-08-08 | 2010-02-23 | Targetex Kft. | Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
AU2003282306A1 (en) * | 2002-10-29 | 2004-05-25 | Engene, Inc. | Compositions for cancer treatment |
CA2524172A1 (en) * | 2003-04-30 | 2004-11-18 | Centocor, Inc. | Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
US7763067B2 (en) * | 2004-09-01 | 2010-07-27 | C. R. Bard, Inc. | Stent and method for manufacturing the stent |
WO2008089438A2 (en) * | 2007-01-18 | 2008-07-24 | The Regents Of The University Of California | A membrane receptor for retinol binding protein mediates cellular uptake of vitamin a, methods of use and compositions |
US20110159017A1 (en) * | 2008-04-11 | 2011-06-30 | Ludwig Institute For Cancer Research Ltd. | Trytophan catabolism in cancer treatment and diagnosis |
EP2445539A4 (en) * | 2009-06-26 | 2015-05-20 | Five Prime Therapeutics Inc | Therapeutic antibody target validation and screening in vivo |
JP6286124B2 (en) * | 2010-01-11 | 2018-02-28 | ジェノミック ヘルス, インコーポレイテッド | A method to determine the likelihood of clinical outcome of renal cancer using gene expression |
SG10201912361VA (en) * | 2010-07-27 | 2020-02-27 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
SG10201605210PA (en) | 2012-01-31 | 2016-08-30 | Genomic Health Inc | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
EP2812350B1 (en) | 2012-02-11 | 2019-04-03 | F.Hoffmann-La Roche Ag | R-spondin translocations and methods using the same |
DK3004392T3 (en) | 2013-05-30 | 2020-10-26 | Genomic Health Inc | GENE EXPRESSION PROFILE ALGORM FOR CALCULATING A RECURRENCY SCORE FOR A PATIENT WITH KIDNEY CANCER |
EP3636661A1 (en) * | 2018-10-12 | 2020-04-15 | Bioc3 | Phosphate translocator |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054963A2 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
WO2001012660A2 (en) * | 1999-08-17 | 2001-02-22 | Sagami Chemical Research Center | HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
FR2413974A1 (en) | 1978-01-06 | 1979-08-03 | David Bernard | DRYER FOR SCREEN-PRINTED SHEETS |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
WO1981001145A1 (en) | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4444545A (en) * | 1982-04-08 | 1984-04-24 | Sanders David F | Pump control system |
US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4485054A (en) * | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
AU597574B2 (en) | 1986-03-07 | 1990-06-07 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
US4676417A (en) * | 1986-04-14 | 1987-06-30 | Richard Hirschkoff | Ski carrier |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
US4997852A (en) | 1987-08-26 | 1991-03-05 | Ohio State University Research Foundation | Method and composition for achieving cancer chemopreventive and chemotherapeutic activity |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
DE3889546T2 (en) | 1987-12-21 | 1994-09-08 | Univ Toledo | TRANSFORMATION OF Germinating PLANT SEEDS WITH THE HELP OF AGROBACTERIUM. |
SE8802525L (en) | 1988-07-06 | 1990-01-07 | Fmg Filipstad Ab | CHAIR |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5009772A (en) | 1989-02-27 | 1991-04-23 | Kerr-Mcgee Corporation | Solvent extraction process |
ATE144281T1 (en) | 1989-04-28 | 1996-11-15 | Rhein Biotech Proz & Prod Gmbh | YEAST CELLS OF THE GENUS SCHWANNIOMYCES |
FR2646437B1 (en) | 1989-04-28 | 1991-08-30 | Transgene Sa | NOVEL DNA SEQUENCES, THEIR APPLICATION AS A SEQUENCE ENCODING A SIGNAL PEPTIDE FOR THE SECRETION OF MATURE PROTEINS BY RECOMBINANT YEASTS, EXPRESSION CASSETTES, PROCESSED YEASTS AND PROCESS FOR PREPARING THE SAME |
WO1990013641A1 (en) | 1989-05-10 | 1990-11-15 | Sloan-Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
ATE144793T1 (en) | 1989-06-29 | 1996-11-15 | Medarex Inc | BISPECIFIC REAGENTS FOR AIDS THERAPY |
FR2649120B1 (en) | 1989-06-30 | 1994-01-28 | Cayla | NOVEL STRAIN AND ITS MUTANTS OF FILAMENTOUS MUSHROOMS, PROCESS FOR PRODUCING RECOMBINANT PROTEINS USING SAID STRAIN, AND STRAINS AND PROTEINS OBTAINED BY SAID METHOD |
WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
KR100272077B1 (en) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
JPH07501451A (en) | 1991-11-25 | 1995-02-16 | エンゾン・インコーポレイテッド | Multivalent antigen binding protein |
US5731167A (en) | 1992-01-17 | 1998-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
US5756448A (en) | 1992-02-26 | 1998-05-26 | The General Hospital Corporation | Constitute activator of retinoid (CAR) receptor polypeptides |
WO1993018186A1 (en) | 1992-03-04 | 1993-09-16 | The Regents Of The University Of California | Comparative genomic hybridization (cgh) |
DE122004000036I1 (en) | 1992-11-13 | 2005-07-07 | Biogen Idec Inc | Therapeutic use of chimeric and labeled antibodies to human B lymphocyte limited differentiation antigen for the treatment of B-cell lymphoma. |
EP0674506B1 (en) | 1992-12-02 | 2000-08-23 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
US5547947A (en) * | 1993-03-11 | 1996-08-20 | Hoffmann-La Roche Inc. | Methods of treatment |
PT616812E (en) | 1993-03-24 | 2000-04-28 | Berlex Biosciences | COMBINATION OF ANTI-HORMONAL COMPOUNDS AND LIGACATION MOLECULES IN CANCER TREATMENT |
WO1996007399A1 (en) | 1994-09-09 | 1996-03-14 | Takeda Chemical Industries, Ltd. | Sustained release preparation containing metal salt of a peptide |
US5681860A (en) | 1993-09-21 | 1997-10-28 | The Trustees Of Columbia University In The City Of New York | Method of increasing expression of HLA, cell surface and TAA antigens of cells using 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US6316007B1 (en) | 1995-04-04 | 2001-11-13 | Wound Healing Of Oklahoma | Combined physical and immunotherapy for cancer |
SK281571B6 (en) | 1995-06-07 | 2001-05-10 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of human growth hormone |
ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
US5871697A (en) * | 1995-10-24 | 1999-02-16 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
US6458939B1 (en) | 1996-03-15 | 2002-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
US6525174B1 (en) * | 1997-06-06 | 2003-02-25 | Human Genome Sciences, Inc. | Precerebellin-like protein |
ATE424457T1 (en) * | 2000-01-13 | 2009-03-15 | Genentech Inc | HUMAN STRA6 POLYPEPTIDES |
EP1334126A1 (en) | 2000-03-23 | 2003-08-13 | Curagen Corporation | Human stra6-like protein and nucleic acids encoding the same |
US20030100710A1 (en) | 2000-06-05 | 2003-05-29 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030187201A1 (en) | 2000-09-15 | 2003-10-02 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030120040A1 (en) | 2001-06-29 | 2003-06-26 | Genentech, Inc. | Secreted and Transmembrane polypeptides and nucleic acids encoding the same |
-
2001
- 2001-01-11 AT AT01904821T patent/ATE424457T1/en active
- 2001-01-11 JP JP2001551209A patent/JP2003519491A/en active Pending
- 2001-01-11 PT PT01904821T patent/PT1246917E/en unknown
- 2001-01-11 NZ NZ520095A patent/NZ520095A/en not_active IP Right Cessation
- 2001-01-11 WO PCT/US2001/000847 patent/WO2001051635A2/en active IP Right Grant
- 2001-01-11 AU AU32768/01A patent/AU785055B2/en not_active Ceased
- 2001-01-11 KR KR1020077028133A patent/KR20080006002A/en not_active Application Discontinuation
- 2001-01-11 US US09/759,056 patent/US7173115B2/en not_active Expired - Fee Related
- 2001-01-11 DK DK01904821T patent/DK1246917T3/en active
- 2001-01-11 EP EP01904821A patent/EP1246917B1/en not_active Expired - Lifetime
- 2001-01-11 ES ES01904821T patent/ES2323220T3/en not_active Expired - Lifetime
- 2001-01-11 CN CN200910147020A patent/CN101643733A/en active Pending
- 2001-01-11 IL IL15067601A patent/IL150676A0/en unknown
- 2001-01-11 CN CN018064965A patent/CN1425066B/en not_active Expired - Fee Related
- 2001-01-11 DE DE60137829T patent/DE60137829D1/en not_active Expired - Lifetime
- 2001-01-11 CA CA2397207A patent/CA2397207C/en not_active Expired - Fee Related
- 2001-07-10 US US09/901,812 patent/US20020173461A1/en not_active Abandoned
-
2002
- 2002-07-10 IL IL150676A patent/IL150676A/en not_active IP Right Cessation
- 2002-07-12 KR KR1020027009049A patent/KR100929057B1/en active IP Right Grant
-
2006
- 2006-05-22 US US11/438,488 patent/US7741439B2/en not_active Expired - Fee Related
- 2006-07-18 US US11/458,237 patent/US20070025998A1/en not_active Abandoned
- 2006-07-18 US US11/458,181 patent/US7939650B2/en not_active Expired - Fee Related
- 2006-11-24 AU AU2006241374A patent/AU2006241374B2/en not_active Ceased
-
2007
- 2007-10-31 US US11/932,861 patent/US7855278B2/en not_active Expired - Fee Related
-
2010
- 2010-11-11 US US12/944,519 patent/US20110171238A1/en not_active Abandoned
-
2011
- 2011-01-21 JP JP2011010411A patent/JP5701624B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054963A2 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
WO2001012660A2 (en) * | 1999-08-17 | 2001-02-22 | Sagami Chemical Research Center | HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
Non-Patent Citations (3)
Title |
---|
BOUILLET PHILIPPE ET AL: "Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein.", MECHANISMS OF DEVELOPMENT, vol. 63, no. 2, 1997, pages 173 - 186, XP001002219, ISSN: 0925-4773 * |
DATABASE EMBL 28 May 1999 (1999-05-28), STRAUSBERG, R.: "wa85b10.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2302939 3', mRNA sequence.", XP002174857 * |
DATABASE EMBL 30 June 1999 (1999-06-30), STRAUSBERG, R.: "wg58f06.x1 Soares_NSF_F8_9W_OT_PA_P_S1 Homo sapiens cDNA clone IMAGE:2369315 3', mRNA sequence.", XP002174858 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999063088A3 (en) | Membrane-bound proteins and nucleic acids encoding the same | |
WO1999028462A3 (en) | Polypeptides and nucleic acids encoding the same | |
WO1999061469A3 (en) | Prostate growth-associated membrane proteins | |
WO2001068848A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2002008288A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999014328A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001051635A3 (en) | Novel stra6 polypeptides | |
WO2001016318A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001040466A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000053756A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000077037A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2002024888A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001007611A3 (en) | Novel polynucleotides and method for the use thereof | |
AU3774300A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000015796A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000036102A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000056889A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000039297A3 (en) | Il-1 related polypeptides | |
WO2003076569A3 (en) | Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same | |
WO2000068376A8 (en) | Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same | |
EP1241179A3 (en) | Human cornichon-like protein and nucleic acids encoding it | |
KR100515858B1 (en) | PRO617 Polypeptides | |
EP1251139A3 (en) | Human mindin-like protein and nucleic acids encoding it | |
EP1241187A3 (en) | Fibilin-like polypeptide and nucleic acids encoding the same | |
EP1241250A3 (en) | Human dehydrogenase-like protein and nucleic acid encoding it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 32768/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 150676 Country of ref document: IL Ref document number: 520095 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2397207 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027009049 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2001 551209 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001904821 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018064965 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027009049 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001904821 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 520095 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 520095 Country of ref document: NZ |